IGM Biosciences, Inc.
IGMSDelisted Aug 14, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001496323
IGM Biosciences, Inc. was delisted on Aug 14, 2025; its insiders filed their last Form 4 on Aug 18, 2025; 66 institutions reported holding it in 13F filings for Q2 2025, worth $17.9M in total; no superinvestor held it.
13F holders, Q1 2022
Institutional positions in IGM Biosciences, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 93
- +6 vs. Q4 2021
- Shares held
- 18.2M
- +608.8K (+3.5%) vs. Q4 2021
- Total value
- $487.4M
- −$30.0M (−5.8%) vs. Q4 2021
- New holders
- 27
- 33 more added
- Sold out
- 21
- 19 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IGMS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 1 | $508 |
| Q2 2025 | 66 | $17.9M |
| Q1 2025 | 79 | $20.5M |
| Q4 2024 | 85 | $132.8M |
| Q3 2024 | 72 | $356.6M |
| Q2 2024 | 82 | $152.9M |
| Q1 2024 | 87 | $220.3M |
| Q4 2023 | 72 | $182.1M |
| Q3 2023 | 79 | $186.3M |
| Q2 2023 | 79 | $207.6M |
| Q1 2023 | 75 | $245.4M |
| Q4 2022 | 82 | $305.8M |
| Q3 2022 | 93 | $402.0M |
| Q2 2022 | 89 | $315.6M |
| Q1 2022 | 93 | $487.4M |
| Q4 2021 | 87 | $517.3M |
| Q3 2021 | 107 | $1.11B |
| Q2 2021 | 105 | $1.36B |
| Q1 2021 | 109 | $1.38B |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding IGM Biosciences, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −25,345−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −22,600−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −12,173−100.0% | Sold out |
| Erste Asset Management GmbH | 0 | $0 | 0.00% | −6,500−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −3,333−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −2,302−100.0% | Sold out |
| Amundi | 0 | $0 | 0.00% | −2,332−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −1,149−100.0% | Sold out |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0 | $0 | 0.00% | −671−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −250−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −70−100.0% | Sold out |
| Tarbox Family Office, Inc. | 0 | $0 | 0.00% | −22−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Covestor Ltd | 0 | $0 | 0.00% | −8−100.0% | Sold out |